Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer
Cancer Science · 2026
DOI: 10.1111/cas.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Yan Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, C…. Hauptthemen laut MEDLINE: Breast Neoplasms, Tumor Suppressor Protein p53, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor suppressor p53 is the most frequently mutated gene in cancers. Mutations in p53 not only result in the loss of its classical tumor‐suppressive functions but also confer new oncogenic properties. The protein stabilization of mutant p53 (mutp53) is a prerequisite for gain‐of‐function manifestation. Here, we report the novel mechanism that pyruvate dehydrogenase kinase1 (PDK1) modulates both wild‐type and mutant p53, and facilitates proliferation and migration of TP53 mutant breast cancer. On the one hand, we identified PDK1 as a direct transcriptional repression target of wild‐type p53, whereas transcriptional activation of PDK1 in mutp53 cells is initiated by the EGR1 axis. On the other hand, PDK1 promoted mutp53 protein accumulation by binding to mutp53 and inhibiting its degradation. Taken together, mutp53 activated a positive feedback loop by upregulating PDK1 to enhance p53 protein stability and promote the malignancy of breast cancer. Moreover, PDK1 inhibition increased the therapeutic effect of APR‐246 on TP53 mutant breast cancer in xenograft tumors. Our results suggested that intervention of PDK1 could potentially emerge as a new therapeutic strategy to impede the progression of TP53 mutant breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
- Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Kejia Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, Y., Ou, Z., Li, C., Liao, Q., Zeng, Q., Ju, X., Zhang, D., Wei, Y., Zhang, X., Zhang, T., & Wu, K. (2026). Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer. Cancer Science. https://doi.org/10.1111/cas.70252
Vancouver
Ye Y, Ou Z, Li C, Liao Q, Zeng Q, Ju X, et al. Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer. Cancer Science. 2026. doi:10.1111/cas.70252
BibTeX
@article{Ye2026,
author = {Ye, Yan and Ou, Zuli and Li, Canling and Liao, Qingyu and Zeng, Qian and Ju, Xiaoqian and Zhang, Dian and Wei, Yu and Zhang, Xiang and Zhang, Tao and Wu, Kejia},
title = {Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70252}
}
EUVIMED